201 related articles for article (PubMed ID: 31981703)
1. Continuous twin screw granulation: Impact of binder addition method and surfactants on granulation of a high-dosed, poorly soluble API.
Portier C; Vigh T; Di Pretoro G; De Beer T; Vervaet C; Vanhoorne V
Int J Pharm; 2020 Mar; 577():119068. PubMed ID: 31981703
[TBL] [Abstract][Full Text] [Related]
2. Continuous twin screw granulation: A complex interplay between formulation properties, process settings and screw design.
Portier C; Pandelaere K; Delaet U; Vigh T; Di Pretoro G; De Beer T; Vervaet C; Vanhoorne V
Int J Pharm; 2020 Feb; 576():119004. PubMed ID: 31935475
[TBL] [Abstract][Full Text] [Related]
3. Influence of binder attributes on binder effectiveness in a continuous twin screw wet granulation process via wet and dry binder addition.
Vandevivere L; Denduyver P; Portier C; Häusler O; De Beer T; Vervaet C; Vanhoorne V
Int J Pharm; 2020 Jul; 585():119466. PubMed ID: 32464227
[TBL] [Abstract][Full Text] [Related]
4. Continuous twin screw granulation: Influence of process and formulation variables on granule quality attributes of model formulations.
Portier C; Pandelaere K; Delaet U; Vigh T; Kumar A; Di Pretoro G; De Beer T; Vervaet C; Vanhoorne V
Int J Pharm; 2020 Feb; 576():118981. PubMed ID: 31935472
[TBL] [Abstract][Full Text] [Related]
5. Continuous twin screw granulation: Robustness of lactose/MCC-based formulations.
Portier C; De Vriendt C; Vigh T; Di Pretoro G; De Beer T; Vervaet C; Vanhoorne V
Int J Pharm; 2020 Oct; 588():119756. PubMed ID: 32783981
[TBL] [Abstract][Full Text] [Related]
6. Development of a controlled release formulation by continuous twin screw granulation: Influence of process and formulation parameters.
Vanhoorne V; Vanbillemont B; Vercruysse J; De Leersnyder F; Gomes P; Beer TD; Remon JP; Vervaet C
Int J Pharm; 2016 May; 505(1-2):61-8. PubMed ID: 27041123
[TBL] [Abstract][Full Text] [Related]
7. Improved tabletability after a polymorphic transition of delta-mannitol during twin screw granulation.
Vanhoorne V; Bekaert B; Peeters E; De Beer T; Remon JP; Vervaet C
Int J Pharm; 2016 Jun; 506(1-2):13-24. PubMed ID: 27094358
[TBL] [Abstract][Full Text] [Related]
8. A novel approach to support formulation design on twin screw wet granulation technology: Understanding the impact of overarching excipient properties on drug product quality attributes.
Willecke N; Szepes A; Wunderlich M; Remon JP; Vervaet C; De Beer T
Int J Pharm; 2018 Jul; 545(1-2):128-143. PubMed ID: 29684559
[TBL] [Abstract][Full Text] [Related]
9. Continuous twin screw granulation: influence of process variables on granule and tablet quality.
Vercruysse J; Córdoba Díaz D; Peeters E; Fonteyne M; Delaet U; Van Assche I; De Beer T; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2012 Sep; 82(1):205-11. PubMed ID: 22687571
[TBL] [Abstract][Full Text] [Related]
10. Identifying Critical Binder Attributes to Facilitate Binder Selection for Efficient Formulation Development in a Continuous Twin Screw Wet Granulation Process.
Vandevivere L; Vangampelaere M; Portier C; de Backere C; Häusler O; De Beer T; Vervaet C; Vanhoorne V
Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33546383
[TBL] [Abstract][Full Text] [Related]
11. Continuous twin-screw granulation for enhancing the dissolution of poorly water soluble drug.
Maniruzzaman M; Nair A; Renault M; Nandi U; Scoutaris N; Farnish R; Bradley MS; Snowden MJ; Douroumis D
Int J Pharm; 2015 Dec; 496(1):52-62. PubMed ID: 26387621
[TBL] [Abstract][Full Text] [Related]
12. Delta-mannitol to enable continuous twin-screw granulation of a highly dosed, poorly compactable formulation.
Vanhoorne V; Almey R; De Beer T; Vervaet C
Int J Pharm; 2020 Jun; 583():119374. PubMed ID: 32339631
[TBL] [Abstract][Full Text] [Related]
13. Scale-up in twin-screw wet granulation: impact of formulation properties.
Franke M; Riedel T; Meier R; Schmidt C; Kleinebudde P
Pharm Dev Technol; 2023 Dec; 28(10):948-961. PubMed ID: 37889884
[TBL] [Abstract][Full Text] [Related]
14. Twin screw granulation as a simple and efficient tool for continuous wet granulation.
Keleb EI; Vermeire A; Vervaet C; Remon JP
Int J Pharm; 2004 Apr; 273(1-2):183-94. PubMed ID: 15010142
[TBL] [Abstract][Full Text] [Related]
15. Integrated twin-screw wet granulation, continuous vibrational fluid drying and milling: A fully continuous powder to granule line.
Fülöp G; Domokos A; Galata D; Szabó E; Gyürkés M; Szabó B; Farkas A; Madarász L; Démuth B; Lendér T; Nagy T; Kovács-Kiss D; Van der Gucht F; Marosi G; Nagy ZK
Int J Pharm; 2021 Feb; 594():120126. PubMed ID: 33321167
[TBL] [Abstract][Full Text] [Related]
16. In-line temperature measurement to improve the understanding of the wetting phase in twin-screw wet granulation and its use in process development.
Stauffer F; Ryckaert A; Vanhoorne V; Van Hauwermeiren D; Funke A; Djuric D; Vervaet C; Nopens I; De Beer T
Int J Pharm; 2020 Jun; 584():119451. PubMed ID: 32454132
[TBL] [Abstract][Full Text] [Related]
17. Faster to First-time-in-Human: Prediction of the liquid solid ratio for continuous wet granulation.
Junnila A; Wikström H; Megarry A; Gholami A; Papathanasiou F; Blomberg A; Ketolainen J; Tajarobi P
Eur J Pharm Sci; 2022 May; 172():106151. PubMed ID: 35217210
[TBL] [Abstract][Full Text] [Related]
18. Simplified end-to-end continuous manufacturing by feeding API suspensions in twin-screw wet granulation.
Schmidt A; de Waard H; Moll KP; Kleinebudde P; Krumme M
Eur J Pharm Biopharm; 2018 Dec; 133():224-231. PubMed ID: 30291963
[TBL] [Abstract][Full Text] [Related]
19. Continuous twin screw granulation: Impact of microcrystalline cellulose batch-to-batch variability during granulation and drying - A QbD approach.
Portier C; Vigh T; Di Pretoro G; Leys J; Klingeleers D; De Beer T; Vervaet C; Vanhoorne V
Int J Pharm X; 2021 Dec; 3():100077. PubMed ID: 33870182
[TBL] [Abstract][Full Text] [Related]
20. The effect of binder types on the breakage and drying behavior of granules in a semi-continuous fluid bed dryer after twin screw wet granulation.
Vandevivere L; Denduyver P; Portier C; Häusler O; De Beer T; Vervaet C; Vanhoorne V
Int J Pharm; 2022 Feb; 614():121449. PubMed ID: 34999149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
